Todd K. Rosengart

Todd K. Rosengart (born January 24, 1960) is an American cardiothoracic surgeon, educator, and researcher, currently serving as the Chair of the Michael E. DeBakey Department of Surgery and Vice President for Hospital Operations and Quality Improvements at Baylor College of Medicine (BCM). In addition, he serves as the DeBakey-Bard Chair and professor of heart and vascular disease at the Texas Heart Institute. He has been a leading researcher in cardiac angiogenesis and regeneration and is known for performing the world's first viral-based gene cardiac transfer procedure. and for his contributions to medical education and technology entrepreneurship. Dr. Rosengart is recognized for his expertise in procedures such as bypass surgery, valve repair, and heart transplantation 
==Early life and education==
Born in Brooklyn, New York and brother to American lawyer, Mathew S. Rosengart.. He completed his M.D. with honors from Northwestern University in 1983 under the mentorship of Dr. Michael Lesch, known for co-discovering the Lesch-Nyhan syndrome . After graduation, he completed an internship and residency in general surgery at New York University Medical Center in 1985, a research fellowship at the National Heart, Lung, and Blood Institute (NIH) in 1987, and a thoracic surgery residency at New York Hospital in 1991. Furthering his training, Rosengart moved to London, UK, to become a senior registrar at The Hospital for Sick Children. He completed his training at The Harley Street Clinic, working with Jaroslav Stark, a pioneer in the use of mathematics to study biological systems. 
==Career==
Prior to joining BCM, Rosengart held several significant positions at the State University of New York at Stony Brook (SUNY-Stony Brook), including professor and chair of the Department of Surgery and Chief of Cardiothoracic Surgery. He also served as the co-director of the Stony Brook Heart Center.
Throughout his career, Rosengart has made substantial contributions to cardiothoracic surgery and heart and vascular disease education, noted for performing the world's first viral-based cardiac gene transfer procedure. Rosengart has made progress in gene therapy to encourage the heart to grow new blood vessels, potentially offering a long-term cure for heart disease; already, 1,000 patients have received the experimental therapy with encouraging results, although objective evidence is still needed to verify its effectiveness. He is co-founder of Vitals.com, now one of the largest medical consumerism companies in the U.S. and XyloCor Therapeutics, a gene therapy company. Moreover, he has secured approximately $15 million in research grants and holds thirteen U.S. patents.
==Research and publications==
Rosengart is a respected researcher and NIH-funded scientist and has over 200 published papers credited to him, with more than 13,500 citations and an h-index of 61. He served as the Editor-In-Chief of the Seminar in Thoracic and Cardiovascular Surgery from 2012 to 2020.
==Memberships==
He holds memberships in several professional societies, including the Leducq Foundation Scientific Advisory Committee, the American College of Cardiology, the American Association for Thoracic Surgery and the American Surgical Association. He served as president of the Society of Surgical Chairs (2019) and co-editor of the Seminars in Thoracic and Cardiovascular Surgery (2013-2016). He is the current Society of Surgical Chair liaison member to the American College of Surgeons Surgical Research Committee.
Category:1960 births
Category:People from Brooklyn, New York
Category:American people
Category:Northwestern University alumni
Category:New York University alumni
Category:Cardiac surgeons
Category:Educators
Category:Researchers